Ondine Biomedical Inc
LSE:OBI
Cash Flow Statement
Cash Flow Statement
Ondine Biomedical Inc
| Mar-2011 | Jun-2011 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
(4)
|
(3)
|
(50)
|
(56)
|
(19)
|
(19)
|
(14)
|
(14)
|
(19)
|
(24)
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
0
|
4
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
(0)
|
(0)
|
37
|
38
|
2
|
2
|
0
|
0
|
1
|
1
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
0
|
0
|
(1)
|
0
|
(0)
|
(0)
|
1
|
2
|
4
|
|
| Cash from Operating Activities |
(4)
N/A
|
(3)
+16%
|
(13)
-320%
|
(19)
-51%
|
(16)
+14%
|
(16)
+1%
|
(14)
+15%
|
(13)
+8%
|
(15)
-23%
|
(19)
-20%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
0
N/A
|
1
+10%
|
(0)
N/A
|
(0)
-345%
|
(0)
+9%
|
(0)
+31%
|
(0)
+18%
|
(0)
+93%
|
(0)
+23%
|
(0)
-140%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
0
|
0
|
37
|
0
|
0
|
0
|
0
|
6
|
0
|
6
|
|
| Net Issuance of Debt |
1
|
2
|
6
|
4
|
(0)
|
(0)
|
4
|
4
|
24
|
24
|
|
| Other |
0
|
0
|
(1)
|
(1)
|
(0)
|
0
|
(1)
|
(1)
|
(2)
|
(1)
|
|
| Cash from Financing Activities |
3
N/A
|
3
+4%
|
42
+1 475%
|
40
-5%
|
(0)
N/A
|
(0)
-18%
|
4
N/A
|
9
+145%
|
22
+134%
|
22
+1%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
1
|
1
|
|
| Net Change in Cash |
(0)
N/A
|
0
N/A
|
29
+13 952%
|
20
-30%
|
(17)
N/A
|
(16)
+2%
|
(10)
+38%
|
(3)
+68%
|
7
N/A
|
4
-38%
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(4)
N/A
|
(3)
+16%
|
(13)
-305%
|
(19)
-52%
|
(17)
+13%
|
(16)
+2%
|
(14)
+15%
|
(13)
+9%
|
(16)
-23%
|
(19)
-20%
|
|